We recently published a list of 15 Best Defensive Stocks Amid Market Volatility In this article, we are going to take a look ...

Key Takeaways The S&P 500 edged 0.2% higher on Tuesday, March 25, 2025, despite a report showing that consumer confidence ...

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

Merck & Co. is flexing its pharmaceutical muscles with strong dividend growth, steady cash flow, and a blockbuster cancer ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...

New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer Research (AACR) ...

The US Vaccines Market, (excluding COVID-19 vaccines), valued at US$25.98 billion in 2024, is forecasted to grow at a robust ...

McKesson's minimal exposure to US-Mexico-Canada tariffs and geopolitical tensions ensures stability. Read why MCK stock is a ...

Revenue grew 9.6% YoY to RMB 18,675.4 million, with non-COVID revenue up 13.1% YoY Adjusted EBITDA grew 14.4% YoY to RMB7,999.3 million and Adjusted Net Profit increased 9.0% YoY to RMB5,396.9 million ...